{"id":"W2979940110","doi":"10.1182/blood.v128.22.613.613","title":"Minimal Residual Disease in Patients with Follicular Lymphoma Treated with Obinutuzumab or Rituximab As First-Line Induction Immunochemotherapy and Maintenance in the Phase 3 GALLIUM Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Obinutuzumab; Follicular lymphoma; Medicine; Minimal residual disease; Bendamustine; Internal medicine; Rituximab; Oncology; Surrogate endpoint; Hazard ratio; Gastroenterology; Immunology; Lymphoma; Leukemia; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001765064,0.0007713693,0.001621985,0.0002127855,0.0002746887,0.00102253,0.000741124,0.0007614481,0.0007335365],"category_scores_gemma":[0.0008952564,0.0003121697,0.001339507,0.0003034599,0.0004142085,0.0004969614,0.0003883479,0.001086033,0.0002056142],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006784639,"about_ca_system_score_gemma":0.0007716432,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009203649,"about_ca_topic_score_gemma":0.00135613,"domain_scores_codex":[0.9995185,0.0002660138,0.00002283376,0.00007049902,0.00004874563,0.0000733329],"domain_scores_gemma":[0.9994486,0.00008179944,0.0001538275,0.00005088075,0.00003286089,0.0002320333],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7710965,0.007256301,0.1239945,0.0006318742,0.003967057,0.0002363286,0.0002730905,0.001549254,0.02302485,0.0001333672,0.001797029,0.0660399],"study_design_scores_gemma":[0.3549863,0.300963,0.3278806,0.0001243605,0.004652333,0.0007137745,0.0001610212,0.002471601,0.004337113,0.0003026876,0.003347529,0.00005967097],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968804,0.002028613,0.0001178547,0.0001213994,0.00002601028,0.0002200684,0.0002582659,0.0000166866,0.0003307587],"genre_scores_gemma":[0.9979804,0.0003762852,0.0002694557,0.0002033636,0.00004291596,0.0002198634,0.0006925599,0.000005574462,0.0002095817],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001765064,"threshold_uncertainty_score":0.009334624,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009680727142649836,"score_gpt":0.2451488242248452,"score_spread":0.2354680970821954,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}